Report overview
This report contains market size and forecasts of End-Stage Renal Disease (ESRD) Drugs in global, including the following market information:
Global End-Stage Renal Disease (ESRD) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global End-Stage Renal Disease (ESRD) Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five End-Stage Renal Disease (ESRD) Drugs companies in 2021 (%)
The global End-Stage Renal Disease (ESRD) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Calcium Succinate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of End-Stage Renal Disease (ESRD) Drugs include CTI BioPharma Corp, Merck & Co Inc, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the End-Stage Renal Disease (ESRD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End-Stage Renal Disease (ESRD) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Type, 2021 (%)
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others
Global End-Stage Renal Disease (ESRD) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
ICU
Others
Global End-Stage Renal Disease (ESRD) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global End-Stage Renal Disease (ESRD) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End-Stage Renal Disease (ESRD) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies End-Stage Renal Disease (ESRD) Drugs revenues share in global market, 2021 (%)
Key companies End-Stage Renal Disease (ESRD) Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies End-Stage Renal Disease (ESRD) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
